We have previously shown that transgenic mice expressing the oncoprotein v-Rel under the control of a T cell–specific promoter develop T cell lymphomas. Tumor formation was correlated with the presence of p50/v-Rel and v-Rel/v-Rel nuclear κB-binding activity. Since experimental evidence has led to the suggestion of a potential tumor suppressor activity for IκBα, we have studied the role of IκBα in the transforming activity of v-Rel by overexpressing IκBα in v-rel transgenic mice. Overexpression of IκBα in v-rel transgenic mice resulted in an extended survival, and the development of cutaneous T cell lymphomas of CD8+CD4− phenotype. These phenotypic alterations were associated with a dramatic reduction of p50/v-Rel, but not v-Rel/v-Rel nuclear DNA binding activity and an increased expression of the intercellular adhesion molecule 1. Our results indicate that v-Rel homodimers are active in transformation and that the capacity of v-Rel–containing complexes to escape the inhibitory effect of IκBα may be a key element in its transforming capability.
IκBα Overexpression Delays Tumor Formation in v-rel Transgenic Mice
Address correspondence to Rodrigo Bravo, Department of Oncology, Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000. Phone: 609-252-5744; FAX: 609-252-3307; E-mail: Bravo#m#[email protected]
1Abbreviations used in this paper: EMSA, electrophoretic mobility shift assay; ICAM-1, intercellular adhesion molecule 1; mRNA, messenger RNA; RHD, Rel homology domain.
These studies were performed according to guidelines established by the Bristol-Myers Squibb Animal Care and Use Committee.
Daniel Carrasco, Paloma Perez, Anne Lewin, Rodrigo Bravo; IκBα Overexpression Delays Tumor Formation in v-rel Transgenic Mice. J Exp Med 21 July 1997; 186 (2): 279–288. doi: https://doi.org/10.1084/jem.186.2.279
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement